-+ 0.00%
-+ 0.00%
-+ 0.00%

Johnson & Johnson Announces European Commission Approves TREMFYA For The Treatment Of Children With Plaque Psoriasis, Marking The First Paediatric Indication For An IL-23 Inhibitor

Benzinga·12/22/2025 15:21:07
Listen to the news